Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Resources
    • Voices
  • Advertise
  • SUBSCRIBE

Bayer and ComGenex Extend Drug Discovery Collaboration

By Pharmaceutical Processing | November 25, 2003

Bayer Healthcare AG and ComGenex announced this week (November 25, 2003) that they have renewed their exclusive chemistry collaborationfor the sixth consecutive year.

“As a result of ComGenex high scientific and quality standards we are gladto continue the collaboration for the coming year,” Dr. Hanno Wild,head of medicinal chemistry at Bayer HealthCare, said. “During the past severalyears ComGenex has built a knowledge base that has great value for Bayer andthat we could efficiently utilize in our drug discovery process. Theflexibility and expertise of ComGenex in responding to Bayer’s high standardsshows that ComGenex is a reliable high-quality partner.”

During the extended term ComGenex will focus on further improving theoverall properties of compound libraries by applying proprietary designcriteria and extending chemical diversity, according to a statement by ComGenex. The provided potentially bioactive compound libraries will be used for applications in all discovery research areas of Bayer HealthCare’s pharma division, the statement said.

“The extension of our collaboration and arrangements shows that theComGenex chemistry team is committed to satisfy the ever-increasing demands ofour partners,” Dr. Laszlo Urge, chief executive officer of ComGenex, said. “Our hard work over the years has paid off and we are glad that we were able to build a knowledge base and service portfolio that leading pharmaceutical companies like Bayer can utilize efficiently in their discovery process.”

ComGenex is a discovery service provider for the pharmaceutical and biotechnology industries. Bayer HealthCare AG, a subgroup of Bayer AG, serves the health care and medical products industry.

Related Articles Read More >

Driving success in fast-paced high-tech pharma construction projects
This is a photo of the Fujifilm Diosynth Biotechnologies plant under construction in Holly Springs, North Carolina.
Fujifilm, Regeneron ink $3B U.S. manufacturing agreement
This is the logo of Johnson & Johnson.
J&J breaks ground on $2B manufacturing facility in North Carolina
sherwin-williams-pharma-facility (1)
Sherwin-Williams expands flooring solutions for pharma facilities
“ppw
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news, technologies, and developments in Pharmaceutical Processing.

DeviceTalks Tuesdays

DeviceTalks Tuesdays

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Pharmaceutical Processing World
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Drug Discovery & Development
  • DeviceTalks
  • MassDevice
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • Medical Design Sourcing
  • Medtech100 Index
  • R&D 100 Awards

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Resources
    • Voices
  • Advertise
  • SUBSCRIBE